v3.21.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Cash flows from operating activities:        
Net loss $ (80,875) $ (23,390) $ (208,656) $ (77,521)
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation 2,109 1,738 6,317 5,179
Non-cash operating lease expense     774 471
Loss on the disposal of property and equipment       9
Debt discount amortization       2,590
Gain on extinguishment of debt   (5,045)   (5,045)
Stock-based compensation     89,758 1,059
Gain on fair value change in contingent earnout share liability (25,764)   (101,166)  
Loss on fair value change in private placement warrants liability     (1,639)  
Changes in operating assets and liabilities:        
Prepaids and other current assets     (8,915) (3,186)
Other assets     (939) 726
Accounts payable     23,920 1,082
Accrued interest expense       7,927
Accrued expenses and other current liabilities     16,647 1,618
Net cash used in operating activities     (180,621) (65,091)
Cash flows from investing activities:        
Purchases of property and equipment     (73,976) (1,209)
Prepayment to VDL Nedcar     (26,134)  
Net cash used in investing activities     (100,110) (1,209)
Cash flows from financing activities:        
Proceeds from related party convertible debt and derivative liability       90,000
Proceeds from issuance of ordinary shares       3
Proceeds from convertible debt       90,500
Loan advance       7,017
Repurchase of restricted ordinary shares     (7) (27)
Proceeds from public warrants exercised     6,879  
Repurchase of unvested shares     (7) (27)
Payment of offering costs     (5,306) (1,307)
Repayment of PPP loan     (6,943)  
Repayments on loan advance       57
Net cash (used in) provided by financing activities     (5,377) 186,129
Net increase in cash, cash equivalents, and restricted cash     (286,108) 119,829
Cash, cash equivalents, and restricted cash, beginning of period     702,422 29,507
Cash, cash equivalents, and restricted cash, end of period 416,314 149,336 416,314 149,336
Reconciliation of cash, cash equivalents, and restricted cash to the condensed consolidated balance sheets        
Cash and cash equivalents at end of period 414,904 148,836 414,904 148,836
Restricted cash 1,410 500 1,410 500
Total cash, cash equivalents, and restricted cash at end of period shown in the condensed consolidated statements of cash flows $ 416,314 $ 149,336 416,314 149,336
Supplemental non-cash investing and financing activities        
Acquisition of property and equipment included in current liabilities     46,774 4,137
Offering costs included in accounts payable     8,001  
Recognition of operating lease right of use asset     2,362  
Conversion of private placement warrants to public warrants     8,252  
Gain on extinguishment of convertible debt recorded in additional paid-in capital       44,785
Deferred offering costs included in accrued and other current liabilities       2,254
Exchange of convertible debt       291,309
Issuance of long-term debt in exchange for loan advance       $ 7,017
Supplemental disclosures of cash flow information        
Cash paid for interest     $ 60  

Source